Literature DB >> 17433076

Granulocyte-macrophage colony-stimulating factor drives monocytes to CD14low CD83+ DCSIGN- interleukin-10-producing myeloid cells with differential effects on T-cell subsets.

Dipyaman Ganguly1, Kausik Paul, Jayashree Bagchi, Srabanti Rakshit, Labanya Mandal, Gautam Bandyopadhyay, Santu Bandyopadhyay.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) has long been found to have growth-promoting effects on multipotent haematopoietic lineages, specifically granulocytes and macrophages. GM-CSF combined with interleukin-4 (IL-4) drives monocytes to become myeloid dendritic cells (mDCs) in vitro. We report that culturing human monocytes with GM-CSF alone generates myeloid cells (GM-Mono) that have lower expression of CD14 than monocytes and that fail to express DC-SIGN. GM-Monos, however, express CD83 and the transcription factor PU.1, although at a lower level than the conventional mDCs generated in the presence of GM-CSF and IL-4. On stimulation with tumour necrosis factor-alpha, interferon-gamma and anti-CD40 monoclonal antibody, the GM-Monos predominantly produced IL-10 but were less efficient in IL-12 production. In a primary allogeneic mixed lymphocyte reaction, GM-Monos induced hyporesponsiveness and IL-10-biased cytokine production in CD4(+) T cells. In fresh mixed lymphocyte reaction, GM-Monos inhibited conventional mDC-induced allogeneic CD4(+) T-cell proliferation. GM-Mono-induced inhibition of allogeneic CD4(+) T-cell proliferation was partially attributed to IL-10. Interestingly, GM-Monos neither induced hyporesponsiveness in allogeneic CD8(+) T cells nor inhibited conventional mDC-induced allogeneic CD8(+) T-cell proliferation. Taken together, we characterize monocyte-derived CD14(low) CD83(+) cells generated by GM-CSF that can induce tolerance or stimulation of T cells depending on T-cell subsets.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17433076      PMCID: PMC2265964          DOI: 10.1111/j.1365-2567.2007.02596.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  45 in total

1.  PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells.

Authors:  A Guerriero; P B Langmuir; L M Spain; E W Scott
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

2.  Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells.

Authors:  K L Anderson; H Perkin; C D Surh; S Venturini; R A Maki; B E Torbett
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

3.  Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.

Authors:  N Romani; D Reider; M Heuer; S Ebner; E Kämpgen; B Eibl; D Niederwieser; G Schuler
Journal:  J Immunol Methods       Date:  1996-09-27       Impact factor: 2.303

4.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages.

Authors:  E W Scott; M C Simon; J Anastasi; H Singh
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

5.  Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells.

Authors:  Panayotis Verginis; Haiyan S Li; George Carayanniotis
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

6.  T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice.

Authors:  H Wada; Y Noguchi; M W Marino; A R Dunn; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

7.  Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Identification of a subset at high risk of treatment failure.

Authors:  R Stasi; L Zinzani; P Galieni; V M Lauta; E Damasio; E Dispensa; F Dammacco; S Tura; G Papa
Journal:  Cancer       Date:  1994-09-15       Impact factor: 6.860

Review 8.  Interleukin-10.

Authors:  K W Moore; A O'Garra; R de Waal Malefyt; P Vieira; T R Mosmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

9.  Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers.

Authors:  T Hartung; W D Döcke; F Gantner; G Krieger; A Sauer; P Stevens; H D Volk; A Wendel
Journal:  Blood       Date:  1995-05-01       Impact factor: 22.113

10.  Phagocytosis of antigens by Langerhans cells in vitro.

Authors:  C Reis e Sousa; P D Stahl; J M Austyn
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  7 in total

1.  DC maturation and function are not altered by melanoma-derived immunosuppressive soluble factors.

Authors:  Joel M Baumgartner; Kimberly R Jordan; Ling-Jia Hu; Cara C Wilson; Anirban Banerjee; Martin D McCarter
Journal:  J Surg Res       Date:  2011-08-24       Impact factor: 2.192

2.  Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue.

Authors:  R W O'Rourke; M D Metcalf; A E White; A Madala; B R Winters; I I Maizlin; B A Jobe; C T Roberts; M K Slifka; D L Marks
Journal:  Int J Obes (Lond)       Date:  2009-06-30       Impact factor: 5.095

3.  Systemic inflammation and insulin sensitivity in obese IFN-γ knockout mice.

Authors:  Robert W O'Rourke; Ashley E White; Monja D Metcalf; Brian R Winters; Brian S Diggs; Xinxia Zhu; Daniel L Marks
Journal:  Metabolism       Date:  2012-03-03       Impact factor: 8.694

4.  Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients.

Authors:  Kimberly R Jordan; Rodabe N Amaria; Oscar Ramirez; Eryn B Callihan; Dexiang Gao; Michelle Borakove; Elizabeth Manthey; Virginia F Borges; Martin D McCarter
Journal:  Cancer Immunol Immunother       Date:  2013-09-27       Impact factor: 6.968

5.  Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab.

Authors:  Richard P Tobin; Kimberly R Jordan; William A Robinson; Dana Davis; Virginia F Borges; Rene Gonzalez; Karl D Lewis; Martin D McCarter
Journal:  Int Immunopharmacol       Date:  2018-08-16       Impact factor: 4.932

6.  15 kDa Granulysin versus GM-CSF for monocytes differentiation: analogies and differences at the transcriptome level.

Authors:  Luciano Castiello; David F Stroncek; Michael W Finn; Ena Wang; Francesco M Marincola; Carol Clayberger; Alan M Krensky; Marianna Sabatino
Journal:  J Transl Med       Date:  2011-04-18       Impact factor: 5.531

7.  The Impact of Integrin β2 on Granulocyte/Macrophage Progenitor Proliferation.

Authors:  Li-Jie Zhang; Cen Yan; Sarah Schouteden; Xiao-Juan Ma; Dong Zhao; Thorsten Peters; Catherine M Verfaillie; Ying-Mei Feng
Journal:  Stem Cells       Date:  2019-02-07       Impact factor: 6.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.